CTLT - Catalent - Stock Price & Dividends

Catalent Inc. is a leading global provider of development and manufacturing solutions for a wide range of healthcare products, including drugs, biologics, cell and gene therapies, and consumer health products.

The company operates through two main segments: Biologics and Pharma and Consumer Health. The Biologics segment focuses on the development and manufacturing of biologic proteins, cell and gene therapies, and nucleic acid-based treatments. This includes services such as formulation, development, and manufacturing for parenteral dose forms, as well as analytical development and testing for large molecules.

In addition, the Biologics segment offers specialized services for the development and manufacturing of vaccines, oncolytic viruses, and pDNA, as well as induced pluripotent stem cells (iPSCs). This segment caters to companies working on cutting-edge treatments and therapies, providing them with the expertise and infrastructure needed to bring their products to market.

The Pharma and Consumer Health segment, on the other hand, provides a range of services for the development and manufacturing of soft capsules, oral solid-dose formats, and other dosage forms. This includes clinical supply services, such as manufacturing, packaging, storage, and distribution, as well as pre-clinical screening and formulation development.

One of the unique strengths of Catalent is its ability to offer integrated development and product supply chain solutions, which enable companies to streamline their product development and commercialization processes. The company's FlexDirect direct-to-patient and FastChain demand-led clinical supply solutions are designed to provide flexibility and efficiency in clinical trials and commercial product distribution.

Catalent serves a diverse range of customers, including pharmaceutical, biotechnology, and consumer health companies, as well as companies in the animal health, medical devices, and cosmetics industries. With a rich history dating back to 1933, the company is headquartered in Somerset, New Jersey, and has established itself as a trusted partner for companies seeking to develop and commercialize innovative healthcare products.